|
Real-time Estimate
Cboe BZX
09:30:13 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 3.585 USD | +0.42% |
|
-4.42% | -7.99% |
| 09-18 | Neuphoria Therapeutics Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-23 | Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $35 million. | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NEUP | Delayed | |
CBOE
| NEUP | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 3.8 | 4.28 | 4.31 |
| Spread/Res. | -6.05% | -16.59% | -17.17% |
| Spread/Supp. | +0.00% | +8.18% | +5.62% |
| Support | 3.57 | 3.3 | 3.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NEUP Stock
- Charts Neuphoria Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
